Select-Lot Varenicline Recall

Pfizer has issued a voluntary consumer-level recall for select lots of varenicline due to nitrosamine content. Visit FDA’s webpage for up-to-date information and guidance for this recallexternal icon as well as information about nitrosamine impurities in medicationsexternal icon. FDA notes patients taking recalled varenicline should continue taking their current medicine until their pharmacist provides a replacement or their doctor prescribes a different medication that treats the same condition. The health benefits of stopping smoking outweigh the cancer risk from the nitrosamine impurity in varenicline. Consult your doctor or pharmacist if you have concerns about your medication.

CDC provides this information as a public service, and this information is not a source of clinical guidance or a substitute for professional medical advice. Persons may consider seeking advice from their healthcare providers. CDC does not endorse any particular company, product, or enterprise.